<DOC>
	<DOCNO>NCT02090907</DOCNO>
	<brief_summary>Hypothyroidism risk factor atherosclerotic cardiovascular disease , controversy effect subclinical hypothyroidism cardiovascular disease . We aim estimate relation subclinical hypothyroidism endothelial dysfunction effect levothyroxine therapy . Patients confirm subclinical hypothyroidism lab result randomize two group treatment one daily dose 100 mg Levothyroxine placebo . The flow-mediated dilation intima medium thickness evaluate study .</brief_summary>
	<brief_title>Effects Levothyroxine Endothelial Function Patients With Subclinical Hypothyroidism</brief_title>
	<detailed_description />
	<mesh_term>Hypothyroidism</mesh_term>
	<criteria>age 18 65 confirmed subclinical hypothyroidism receive treatment hypothyroidism patient major medical disorder smoke hyperlipidemia obesity</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>Subclinical hypothyroidism</keyword>
	<keyword>Atherosclerosis</keyword>
	<keyword>Cardiovascular disease</keyword>
	<keyword>Endothelial function</keyword>
	<keyword>Prevention</keyword>
</DOC>